Association between single nucleotide polymorphisms of DNA repair genes (BRCA1, BRCA2, and PALB2) and breast cancer incidence in a subset of Iranian population

被引:0
|
作者
Jahangiri, Sepideh [1 ]
Abdan, Zahra [1 ]
Houshmand, Massoud [2 ]
Souroush, Ali [3 ]
Aznab, Mozaffar [1 ,4 ]
机构
[1] Kermanshah Univ Med Sci, Clin Res Dev Ctr, Imam Reza Hosp, Kermanshah, Iran
[2] Natl Inst Genet & Biotechnol, Dept Med Genet, Tehran, Iran
[3] Kermanshah Univ Med Sci, Dept Med Phys, Kermanshah, Iran
[4] Kermanshah Univ Med Sci, Internal Med Dept, Med Oncol Hematol, Kermanshah, Iran
关键词
Breast cancer; BRCA1; BRCA2; PALB2; Polymorphism; TURKISH POPULATION; MUTATIONS; SUSCEPTIBILITY; RISK;
D O I
10.1186/s13053-025-00311-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundBreast cancer (BC) is the most common malignancy among Iranian females, accounting for 24.4% of all malignancies. Germ line mutations in DNA repair system-related genes are associated with an increased risk of BC. This study aims to evaluate the frequencies of single nucleotide polymorphisms (SNPs) in the BRCA1, BRCA2, and PALB2 genes in patients with BC from a subset of the Iranian population in the western part of Iran.MethodsBlood samples were collected from 335 patients with BC and 354 healthy matched volunteers. Genomic DNA was extracted using the salting-out method and, after quality control, was genotyped using the multiplex TaqMan allelic discrimination assay for three SNPs: rs80359550 (6174 delT) in the BRCA2 gene, rs180177102 in the PALB2 gene, and rs386833395 (185delAG) in the BRCA1 gene. Statistical analysis was performed to examine allele frequency, odds ratio, and relative risk (genetic association) in a retrospective case-control study.ResultsThe data showed no association between rs386833395 and BC risk in the studied population (odds ratio = 1), whereas rs80359550 and rs180177102 polymorphisms were strongly associated with BC risk in patients (odds ratio = 0.01 for both, with p-values of 0.011 and 0.021, respectively).ConclusionsOur findings suggest no significant association between the rs386833395 polymorphism and BC risk in the Iranian Kurdish population, while rs80359550 and rs180177102 polymorphisms were strongly associated with BC. However, the study has several limitations, including its retrospective design, a relatively small sample size, and the potential lack of generalizability to other ethnic groups within Iran. Future studies involving larger cohorts and more diverse populations are needed to confirm these results.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] NGS-based BRCA1, BRCA2, and PALB2 mutation testing in Iranian population with breast cancer
    Ebrahimi, E.
    Zendehdel, K.
    Sellars, E.
    Ghiasvand, R.
    Harirchi, I.
    Shirkoohi, R.
    Akbari, M. R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 531 - 532
  • [2] PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2
    Zhang, Fan
    Fan, Qiang
    Ren, Keqin
    Andreassen, Paul R.
    MOLECULAR CANCER RESEARCH, 2009, 7 (07) : 1110 - 1118
  • [3] Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families
    Pylkas, Katri
    Erkko, Hannele
    Nikkila, Jenni
    Solyom, Szilvia
    Winqvist, Robert
    BMC CANCER, 2008, 8 (1)
  • [4] Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families
    Katri Pylkäs
    Hannele Erkko
    Jenni Nikkilä
    Szilvia Sólyom
    Robert Winqvist
    BMC Cancer, 8
  • [5] PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
    Zhang, Feng
    Ma, Jianglin
    Wu, Jiaxue
    Ye, Lin
    Cai, Hong
    Xia, Bing
    Yu, Xiaochun
    CURRENT BIOLOGY, 2009, 19 (06) : 524 - 529
  • [6] Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
    Wojcik, P.
    Jasiowka, M.
    Strycharz, E.
    Sobol, M.
    Hodorowicz-Zaniewska, D.
    Skotnicki, P.
    Byrski, T.
    Blecharz, P.
    Marczyk, E.
    Cedrych, I.
    Jakubowicz, J.
    Lubinski, J.
    Sopik, V.
    Narod, S.
    Pierzchalski, P.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2016, 14
  • [7] Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
    P. Wojcik
    M. Jasiowka
    E. Strycharz
    M. Sobol
    D. Hodorowicz-Zaniewska
    P. Skotnicki
    T. Byrski
    P. Blecharz
    E. Marczyk
    I. Cedrych
    J. Jakubowicz
    J. Lubiński
    V. Sopik
    S. Narod
    P. Pierzchalski
    Hereditary Cancer in Clinical Practice, 14
  • [8] A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago
    Donenberg, Talia
    Ahmed, Humayun
    Royer, Robert
    Zhang, Shiyu
    Narod, Steven A.
    George, Sophia
    Akbari, Mohammad R.
    Ali, Jameel
    Hurley, Judith
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 131 - 138
  • [9] A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago
    Talia Donenberg
    Humayun Ahmed
    Robert Royer
    Shiyu Zhang
    Steven A. Narod
    Sophia George
    Mohammad R. Akbari
    Jameel Ali
    Judith Hurley
    Breast Cancer Research and Treatment, 2016, 159 : 131 - 138
  • [10] BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer
    Shehaj, Ina
    Krajnak, Slavomir
    Almstedt, Katrin
    Degirmenci, Yaman
    Herzog, Sophia
    Lebrecht, Antje
    Linz, Valerie Catherine
    Schwab, Roxana
    Stewen, Kathrin
    Brenner, Walburgis
    Hasenburg, Annette
    Schmidt, Marcus
    Heimes, Anne-Sophie
    BIOMEDICINES, 2024, 12 (06)